Home » Stocks » NAOV

NanoVibronix, Inc. (NAOV)

Stock Price: $0.588 USD -0.022 (-3.65%)
Updated Oct 29, 2020 4:00 PM EDT - Market closed
After-hours: $0.580 -0.008 (-1.39%) Oct 29, 7:20 PM

Stock Price Chart

Key Info

Market Cap 5.60M
Revenue (ttm) 571,000
Net Income (ttm) -4.41M
Shares Out 9.52M
EPS (ttm) -0.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 29, 2020
Last Price $0.588
Previous Close $0.611
Change ($) -0.022
Change (%) -3.65%
Day's Open 0.601
Day's Range 0.566 - 0.617
Day's Volume 394,226
52-Week Range 0.535 - 3.500

More Stats

Market Cap 5.60M
Enterprise Value 5.52M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 9.52M
Float 8.30M
EPS (basic) -0.62
EPS (diluted) -0.62
FCF / Share -0.49
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 44,387
Short Ratio 0.00
Short % of Float 0.53%
Beta -0.34
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9.81
PB Ratio 13.73
Revenue 571,000
Operating Income -4.41M
Net Income -4.41M
Free Cash Flow -3.52M
Net Cash 83,000
Net Cash / Share 0.01
Gross Margin 49.21%
Operating Margin -771.80%
Profit Margin -771.60%
FCF Margin -616.99%
ROA -133.84%
ROE -765.59%
ROIC -3,034.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$10.50*
Low
10.5
Current: $0.588
High
10.5
Target: 10.50
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue0.530.320.240.230.150.200.210.17
Revenue Growth66.67%33.05%4.37%55.78%-27.59%-3.79%27.11%-
Gross Profit0.280.160.150.140.100.110.120.12
Operating Income-5.15-4.30-3.09-2.32-1.42-1.21-1.11-0.77
Net Income-5.79-4.15-4.97-2.83-2.88-2.65-1.99-1.28
Shares Outstanding6.946.454.964.583.540.160.160.16
Earnings Per Share-0.83-0.64-1.17-0.62-0.82-17.08-12.83-8.23
Operating Cash Flow-3.87-3.55-2.18-1.53-1.48-0.90-0.60-0.79
Capital Expenditures--0.01--0.01---0.01-0.01
Free Cash Flow-3.87-3.56-2.18-1.54-1.48-0.90-0.61-0.79
Cash & Equivalents1.340.904.360.111.610.090.090.10
Total Debt-----4.623.111.95
Net Cash / Debt1.340.904.360.111.61-4.53-3.01-1.85
Assets2.041.584.870.491.980.720.690.35
Liabilities0.691.121.232.992.196.343.992.18
Book Value1.350.463.63-2.50-0.21-5.62-3.30-1.83
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name NanoVibronix, Inc.
Country United States
Employees 10
CEO Brian M. Murphy

Stock Information

Ticker Symbol NAOV
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: NAOV

Description

NanoVibronix, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.